These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 33637328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [Abstract] [Full Text] [Related]

  • 3. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
    Micic D, Robinson I, Kidd T, Terreri B, Raphael BP.
    Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
    Gondolesi GE, Pape UF, Mason JB, Allard JP, Pironi L, Casas MNV, Schwartz LK, Joly F, Gabriel A, Sabrdaran S, Zhang P, Kohl-Sobania M, Huang YW, Jeppesen PB.
    Nutrients; 2024 Aug 01; 16(15):. PubMed ID: 39125394
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M, Billiauws L, Joly F.
    Curr Opin Clin Nutr Metab Care; 2023 Sep 01; 26(5):449-454. PubMed ID: 37421385
    [Abstract] [Full Text] [Related]

  • 13. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S, Maasberg S, Rieger A, Karber M, Blüthner E, Knappe-Drzikova B, Thurmann D, Büttner J, Weylandt KH, Wiedenmann B, Müller VA, Bläker H, Pascher A, Pape UF.
    Clin Nutr; 2019 Aug 01; 38(4):1745-1755. PubMed ID: 30145039
    [Abstract] [Full Text] [Related]

  • 14. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B.
    Gastroenterology; 2012 Dec 01; 143(6):1473-1481.e3. PubMed ID: 22982184
    [Abstract] [Full Text] [Related]

  • 15. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW, Hill S, Robinson I, Raphael BP, Matthews C, Cohran V, Carter B, Venick R, Kocoshis S.
    J Pediatr Gastroenterol Nutr; 2024 Aug 01; 79(2):290-300. PubMed ID: 38873891
    [Abstract] [Full Text] [Related]

  • 16. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K, Mu F, Xie J, Kelkar SS, Olivier C, Signorovitch J, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2020 Jan 01; 44(1):119-128. PubMed ID: 31006876
    [Abstract] [Full Text] [Related]

  • 17. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F, Seguy D, Nuzzo A, Chambrier C, Beau P, Poullenot F, Thibault R, Armengol Debeir L, Layec S, Boehm V, Lallemand J, Quilliot D, Schneider SM.
    Clin Nutr; 2020 Sep 01; 39(9):2856-2862. PubMed ID: 31932048
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S, Maasberg S, Wehkamp J, Fusco S, Zopf Y, Herrmann HJ, Lamprecht G, Jacob T, Schiefke I, von Websky MW, Büttner J, Blüthner E, Tacke F, Pape UF.
    Clin Nutr ESPEN; 2022 Oct 01; 51():222-230. PubMed ID: 36184208
    [Abstract] [Full Text] [Related]

  • 19. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE, Wendel D, Horslen SP.
    Expert Rev Gastroenterol Hepatol; 2021 Jul 01; 15(7):727-733. PubMed ID: 33798402
    [Abstract] [Full Text] [Related]

  • 20. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H.
    J Clin Gastroenterol; 2017 Jul 01; 51(6):508-511. PubMed ID: 27433811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.